VICTORIA WYNNE: Open Payments
NPI 1053071506 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 6 payments from 2 companies in 2025. Trend: 2023 $664 · 2024 $191 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 3 | $224 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
Products named: REMODULIN, ORENITRAM, LEQVIO.
Industry payments across TX — which companies pay providers there.
